Search results for "Thrombosis"
Drug may reduce transfusions but increase thrombosis in liver disease patients having elective invasive procedures
Eltrombopag, an oral thrombopoietin-receptor agonist, may reduce the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing invasive elective procedures, but risk for portal-vein thrombosis may increase, according to a new industry-funded study.
https://immattersacp.org/weekly/archives/2012/08/28/6.htm
28 Aug 2012
AHA issues statement on cerebral venous thrombosis diagnosis, management
MKSAP Quiz: drug-resistant hypertension
https://immattersacp.org/weekly/archives/2011/02/15/2.htm
15 Feb 2011
Register now for ACP's live, virtual POCUS Mentorship Program
Upcoming point-of-care ultrasound (POCUS) training will help physicians perfect their skills in diagnostic examinations of the lungs, heart, kidneys, bladder, abdomen, and lower extremities.
https://immattersacp.org/weekly/archives/2023/02/14/6.htm
14 Feb 2023
PCP follow-up after surgery associated with lower readmission rates
Medicare beneficiaries hospitalized for an emergency general surgery condition had a 67% lower adjusted risk for readmission if they had a follow-up appointment with a primary care physician (PCP) within 30 days of discharge.
https://immattersacp.org/weekly/archives/2023/10/03/4.htm
3 Oct 2023
MKSAP Quiz: Evaluation for easy bruising
A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Following a physical exam and lab studies, what is the most appropriate diagnostic test?
https://immattersacp.org/weekly/archives/2023/03/28/3.htm
28 Mar 2023
MKSAP Quiz: Right-upper-quadrant abdominal discomfort
A 36-year-old woman is evaluated for a 3-day history of constant right-upper-quadrant abdominal discomfort and abdominal distention. She has no significant medical history. Following a physical exam and lab tests, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2021/10/19/3.htm
19 Oct 2021
Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk
Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://immattersacp.org/weekly/archives/2020/10/20/5.htm
20 Oct 2020
Patients with provoked VTE often on anticoagulation longer than recommended
Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://immattersacp.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022
Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021